Mendlik et al., 2012 - Google Patents
Effects of fructooligofructoses chain length on the bifidobacteria of the human colon: a pilot studyMendlik et al., 2012
View HTML- Document ID
- 16096325692960348714
- Author
- Mendlik K
- Albrecht J
- Schnepf M
- Publication year
External Links
Snippet
Human gastrointestinal health may be improved by the consumption of prebiotic food ingredients such as fructooligo-fructoses. A study was initiated to determine the effect of fructooligofructoses of different chain lengths on gastrointes-tinal parameters. Nineteen …
- 241000186000 Bifidobacterium 0 title abstract description 44
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Rational use of prebiotics for gut microbiota alterations: Specific bacterial phylotypes and related mechanisms | |
Grabinger et al. | Alleviation of intestinal inflammation by oral supplementation with 2-fucosyllactose in mice | |
Sivieri et al. | Prebiotic effect of fructooligosaccharide in the simulator of the human intestinal microbial ecosystem (SHIME® model) | |
Bird et al. | Starches, resistant starches, the gut microflora and human health | |
JP7273725B2 (en) | Novel bifidobacterium bacterium and composition containing the bacterium | |
Roberfroid | Introducing inulin-type fructans | |
Pompei et al. | In vitro comparison of the prebiotic effects of two inulin-type fructans | |
AU2014278835B2 (en) | Synbiotic composition for treatment of infections in allergic patients | |
Macfarlane | Prebiotics in the gastrointestinal tract | |
Calame et al. | Gum arabic establishes prebiotic functionality in healthy human volunteers in a dose-dependent manner | |
Johnson et al. | The human microbiome and its potential importance to pediatrics | |
Tanner et al. | Synergistic effects of Bifidobacterium thermophilum RBL67 and selected prebiotics on inhibition of Salmonella colonization in the swine proximal colon PolyFermS model | |
CN107198250A (en) | Improve intestinal microecology Chronic disease prevention composition and balanced nutritious food and application | |
WO2017057718A1 (en) | Food and drink product containing poorly digestible compound and colonic-hydrogen-gas producing agent | |
Sarbini et al. | Prebiotics: metabolism, structure, and function | |
CN101945658A (en) | A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants | |
Mendlik et al. | Effects of fructooligofructoses chain length on the bifidobacteria of the human colon: a pilot study | |
WO2022161865A1 (en) | Mixture of hmos and bifidobacteria | |
JP2017501180A (en) | Nutritional composition for reducing enteric pathogens | |
Alexiou et al. | Prebiotic inulin‐type fructans: nutritional benefits beyond dietary fibre source | |
MacDonald et al. | Specific prebiotics in a formula for infants with Phenylketonuria | |
Mullin et al. | The human gut microbiome and its role in obesity and the metabolic syndrome | |
Mitsou et al. | Impact of a jelly containing short-chain fructo-oligosaccharides and Sideritis euboea extract on human faecal microbiota | |
Mansouri | Viability of Bifidobacterium bifidum and Escherichia coli in versus prebiotic effects of Jerusalem artichoke (Helianthus tuberosus) | |
Sant’Anna et al. | Can intestinal constipation be modulated by prebiotics, probiotics and Symbiotics? |